Trial Profile
Comparison of Oxybutynin and Solifenacin in the Treatment of Overactive Bladder: a Randomized Controlled Multicenter Trial
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 21 Nov 2023
Price :
$35
*
At a glance
- Drugs Oxybutynin (Primary) ; Solifenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 29 Aug 2011 New trial record